Stemgent Sponsors Harvard Seminar Series
Stemgent announced today the financial sponsorship of the Seminar Series Fund at the Harvard Stem Cell Institute.
September 1, 2009
Stemgent announced today the financial sponsorship of the Seminar Series Fund at the Harvard Stem Cell Institute.
Once again, applications of adult stem cell therapy in veterinary medicine continue to race ahead of human medicine.
The company Vitro Biopharma has announced the development of new cancer therapies based upon adult stem cells.
The adult stem cell company Cardio3 BioSciences presents an update on its heart failure therapy at the annual conference of the European Society of Cardiology.
Scientists create insulin-producing cells from iPS cells derived from the skin of people with Type I diabetes.
Surgeons in England are repairing damaged bones, joints and cartilage with adult stem cells, thereby rendering hip replacements unnecessary.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.